Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-194-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"lt"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-194-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-195-0002
lpv:speaker	lp:Zigmantas Balčytis2
lpv:spokenAs	member; S&D (2009-07-14--2014-06-30)3 unknown; Lietuvos socialdemokratų partija (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the United States (2009-09-16--2014-06-30)3 member; CONT (2009-07-16--2012-01-18)3 member; Delegation for relations with the People's Republic of China (2009-09-16--2014-06-30)3 member; ITRE (2009-07-16--2012-01-18)3 substitute; TRAN (2009-07-16--2012-01-18)3 substitute; Special committee on the policy challenges and budgetary resources for a sustainable European Union after 2013 (2010-06-17--2011-06-30)3
lpv:translated text	"I voted in favour of this important document. The report presented by the Commission notes that seizures of falsified medicines are increasing, and that life-saving medicines intended to treat cancer and heart disease are being falsified. Falsified medicines are also increasingly finding their way into the licensed distribution chain. This poses a major threat to the health of EU citizens. Falsifying of medicinal products must be viewed as a criminal act that denies patients the necessary medical treatment and is harmful to their health, sometimes even leading to their death. Therefore the objective of the directive should be the protection of public health, ensuring a high level of quality control of the import of medicinal products, since this is one of the key entry doors of falsified medicines to the European market. Furthermore, it is crucial to create an inspections system and an efficient falsification detection system. I believe that it is essential to properly regulate and control the sale of medicines on the Internet, because this is one of the main routes for falsified medicinal products to enter the European market."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph